PubMed:28326881 / 726-1263 JSONTXT

Annnotations TAB JSON ListView MergeView

{"target":"https://pubannotation.org/docs/sourcedb/PubMed/sourceid/28326881","sourcedb":"PubMed","sourceid":"28326881","text":"Compared with the placebo, probiotic supplementation resulted in significant decreases in fasting plasma glucose (FPG) (-5.3 ± 6.7 vs. +0.03 ± 9.0 mg/dL, p = .01), serum high-sensitivity C-reactive protein (hs-CRP) (-2.2 ± 2.7 vs. +0.5 ± 2.4 μg/mL, p \u003c .001), plasma malondialdehyde (MDA) concentrations (-0.1 ± 0.8 vs. +0.5 ± 1.5 μmol/L, p = .03) and MDA/TAC ratio (-0.0003 ± 0.0008 vs. +0.0009 ± 0.002, p = .004), and a significant increase in total antioxidant capacity (TAC) levels (+65.4 ± 103.3 vs. -37.2 ± 143.7 mmol/L, p = .002).","tracks":[{"project":"Inflammaging","denotations":[{"id":"T8","span":{"begin":0,"end":537},"obj":"Sentence"},{"id":"T8","span":{"begin":0,"end":537},"obj":"Sentence"}],"attributes":[{"subj":"T8","pred":"source","obj":"Inflammaging"},{"subj":"T8","pred":"source","obj":"Inflammaging"}]},{"project":"yangbin123xm_800_3","denotations":[{"id":"T11","span":{"begin":18,"end":25},"obj":"CI"}],"attributes":[{"subj":"T11","pred":"source","obj":"yangbin123xm_800_3"}]},{"project":"chenxin_473849_800_3","denotations":[{"id":"T11","span":{"begin":18,"end":25},"obj":"CI"}],"attributes":[{"subj":"T11","pred":"source","obj":"chenxin_473849_800_3"}]}],"config":{"attribute types":[{"pred":"source","value type":"selection","values":[{"id":"Inflammaging","color":"#eca293","default":true},{"id":"yangbin123xm_800_3","color":"#939dec"},{"id":"chenxin_473849_800_3","color":"#b7ec93"}]}]}}